This association of APOE4 allele status with an altered response to pain in a cognitively healthy sample of adults suggests that thermal evoked pain testing could serve as a potential phenotypic biomarker of individuals at increased risk for AD (Romano et al., 2021). The gene discussed is APOE; the disease is Alzheimer disease.